Where is the patent that's going to put SQNM out of business if a big pharma gets a hold of.
EXAS patents are not THAT valuable which is reflected in SQNM's bid. A poop test for Downs is not a threat. Maybe a poop test for CRC is valuable and that's what they're after but if EXAS doesn't sell - it's no big deal.
"Exact’s announcement follows close on the heels of a prodding SEC filing made by Kenneth Luskin, founder of Santa Monica, CA-based Intrinsic Value Asset Management. The filing said that Luskin—whose fund owns 8 percent of Exact’s common stock—had recently “communicated with [Exact] and to members of its board of directors great concerns about serious deficiencies in the management of the [firm].”